Ekf Diagnostics Holding PLC : 19 November 2013. EKF Diagnostics Acute …4-traders (press release)EKF Diagnostics Holdings plc, the AIM listed point-of-care diagnostics business, announces that the development of a Point of Care platform for Acute Kidn…
Science Codex |
Heart failure patients receiving LVAD benefit from injection of millions of …
News-Medical.net A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network (CTSN), led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left ventricular … Mesoblast’s Cell Therapy Strengthens Native Heart Function In Patients With …GlobeNewswire (press release) |
Drug shows promise in treating liver failure-related seizures: Study by Nature …pharmabiz.comAccording to a study published in the journal Nature Medicine has suggested that a potential new treatment for seizures that often plague children with genet…
Drug Shows Early Promise In Treating SeizuresRedOrbitA study out today in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failu…
|
Drug Shows Early Promise in Treating Liver Failure-Related Seizures
Drug Discovery & Development A study in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure. The discovery hinges on a new understanding of the complex … |
Mayo Clinic-led Study: Two Drugs do not Improve Kidney Function in Acute …HealthCanal.comPrevious smaller studies showed that low-dose dopamine or low-dose nesiritide could improve kidney function and reduce fluid overload that is often present in ho…
New Study Shows Spironolactone Reduces Heart Failure Hospitalizations, But …HealthCanal.comBoston, MA – A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, …
Medscape |
Spironolactone Reduces Heart Failure Hospitalizations, but Not Mortality …
Science Daily (press release) 18, 2013 — A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013 … AHA: Decision on Spironolactone in HF a Toss-Up?MedPage Today Aldo-Antagonist Falls Short but Impresses in Preserved-EF Heart Failure: TOPCATMedscape |
New study shows spironolactone reduces heart failure hospitalizations, but not …Eureka! Science NewsA late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to b…
|
Two Drugs Do Not Improve Kidney Function in Acute Heart Failure Patients
Science Daily (press release) 18, 2013 — Two drugs tested in a larger trial did not improve kidney function in acute heart failure patients, contrary to results of smaller studies. The results were presented today at the American Heart Association’s Scientific Sessions 2013 in … Two drugs didn’t improve kidney function in acute heart failureHealthCanal.com |